Table 1a.
Cerebellum phospholipid mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 11965 | 12228 | 4572 | 38.1% | 37.8% | 1.4% |
| PtdIns | 1173 | 1445 | 137 | 3.7% | 4.8% | 1.4% |
| PtdSer | 3103 | 3228 | 1625 | 9.9% | 9.7% | 1.7% |
| ChoGpl | 11947 | 12100 | 3660 | 38.1% | 38.1% | 1.8% |
| CerPCho | 3208 | 3123 | 1130 | 10.2% | 9.7% | 0.2%* |
| Total | 31397 | 32125 | 11103 | |||
| n = 1 | n = 3 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
*
indicates significance between patient and control group, 2 SD from control mean.